/

Companies / Access Bio

Access Bio

United States

Access Bio develops in vitro diagnostics technology and commercializes products to battle diseases such as malaria and COVID-19.

Access Bio, based in United States, has 1 investor on file, among them Global Health Investment Corporation. Its site was last checked 7 Nov 2026: site answers.

SEC Form D filings

3 filings

Filed by ACCESS BIO, INC. with the SEC. A Form D reports a private offering; it is not a priced round.

Investors

1 investor on file
InvestorEvidenceType
Global Health Investment CorporationPortfolio pageInvestor

More from Global Health Investment Corporation

22 companies on its checked portfolio

Its portfolio leans to Healthcare & Biotech (92%), Media & Entertainment (4%), Cybersecurity (4%).

See Global Health Investment Corporation's full profile · Who invests alongside it

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Access Bio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Global Health Investment Corporation adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/accessbio.net/investors

# also
GET /v1/companies/accessbio.net
GET /v1/companies/accessbio.net/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing